NDC 43772-0021

Lymesode

Chelidonium Majus, Echinacea (angustifolia), Hydrastis Canadensis, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Toxicodendron, Arnica Montana,

Lymesode is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Synergy Formulas, Inc.. The primary component is Chelidonium Majus; Echinacea Angustifolia; Goldenseal; Nasturtium Aquaticum; Taraxacum Officinale; Trifolium Pratense Flower; Toxicodendron Pubescens Leaf; Arnica Montana; Sus Scrofa Adrenal Gland; Sus Scrofa Bone Marrow; Sus Scrofa Thymus; Oxalic Acid; Magnesium Phosphate, Dibasic Trihydrate; Latrodectus Mactans; Borrelia Burgdorferi; Japanese Encephalitis Virus; Neisseria Meningitidis; Hepatitis B Virus.

• Product ID: 43772-0021_8a825f9d-8892-45bb-b404-8537ccb0bbae
• NDC: 43772-0021
• Product Type: Human Otc Drug
• Proprietary Name: Lymesode
• Generic Name: Chelidonium Majus, Echinacea (angustifolia), Hydrastis Canadensis, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Toxicodendron, Arnica Montana,
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2014-06-23
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Synergy Formulas, Inc.
• Substance Name: CHELIDONIUM MAJUS; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; NASTURTIUM AQUATICUM; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; TOXICODENDRON PUBESCENS LEAF; ARNICA MONTANA; SUS SCROFA ADRENAL GLAND; SUS SCROFA BONE MARROW; SUS SCROFA THYMUS; OXALIC ACID; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; LATRODECTUS MACTANS; BORRELIA BURGDORFERI; JAPANESE ENCEPHALITIS VIRUS; NEISSERIA MENINGITIDIS; HEPATITIS B VIRUS
• Active Ingredient Strength: 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 43772-0021-1

60 mL in 1 BOTTLE, DROPPER (43772-0021-1)

• Marketing Start Date: 2014-06-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 43772-0021-1 [43772002101]

Lymesode LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2014-06-23
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
CHELIDONIUM MAJUS	3 [hp_X]/mL

OpenFDA Data

• SPL SET ID: 1c48c08e-e4a3-4238-a71d-80c799ec1236
• Manufacturer:
  • Synergy Formulas, Inc.
• UNII:
  • 39981FM375
  • VP2CN2G7Y8
  • 77H9EM77P7
  • 0J8NV9V5Q8
  • 7B69B0BD62
  • O80TY208ZW
  • 6IO182RP7A
  • ZW3Z11D0JV
  • XJJ7QA858R
  • 7E889U5RNN
  • V3TP2MD7F3
  • 398IYQ16YV
  • 4JS0838828
  • P07E7XWU9D
  • 9E7R5L6H31
  • VB06AV5US8
  • HF539G9L3Q

NDC Crossover Matching brand name "Lymesode" or generic name "Chelidonium Majus, Echinacea (angustifolia), Hydrastis Canadensis, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Toxicodendron, Arnica Montana,"

NDC	Brand Name	Generic Name
43772-0021	Lymesode	Chelidonium majus, Echinacea (Angustifolia), Hydrastis canadensis, Nasturtium aquaticum, Taraxacum officinale, Trifolium pratense, Rhus toxicodendron, Arnica montana,
43772-0038	Lymesode	Echinacea (Angustifolia), Hydrastis Canadensis, Lycopodium Clavatum, Nasturtium Aquaticum, Taraxacum Officinale, Trifolium Pratense, Rhus Tox, Arnica Montana, Glandula Suprarenalis Suis, Medulla Ossis Suis, Thymus (Suis), Oxalicum Acidum, Magnesia Phosphorica, Latrodectus Mactans, Borrelia Burgdorferi Nosode, Encephalitis Nosode, Meningococcus Nosode, Hepatitis B Nosode